Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2018 – 30 april 2019.
PHI and RegenMed Development Organization have entered a partnership to advance large-scale biomanufacturing of cell-based therapies.
The strategic shift to focus on digital sales & marketing has been successful, reflected in the sales increase during the latter part of the fiscal year.
The regenerative medicine company Pandorum Technology recently purchased a complete HoloMonitor system.
